Year: 2025

Industry Veteran to discuss branding and market strategy NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), announced today that David Vautrin, Interim CEO will speak at the Business of Cannabis: New York Summit on Thursday, November 6, 2025, at the Wythe Hotel in Williamsburg, Brooklyn. “We are delighted to welcome David Vautrin center stage at the upcoming Business of Cannabis: New York,” said Matt Freemantle, Managing Director – Media & Events Prohibition Partners. “David brings a wealth of insight and experience to the industry. He joined us earlier this year in Berlin, Germany for a panel during the first ever Business of Cannabis x Mary Jane Berlin international b2b day, where he shared his deep knowledge of the evolving cannabis landscape. We’re thrilled...

Fingrid follows a six-month reporting period in compliance with the Securities Markets Act and publishes Management’s Reviews for the first three and nine months of the year; the Management’s Reviews contain key information illustrating the company’s financial and other development. The information presented in the Management’s Review relates to Fingrid Group’s performance in January–September 2025 and the corresponding period of 2024, unless otherwise indicated. The figures presented here have been drawn up in accordance with the International Financial Reporting Standards (IFRS). The Management’s Review is not an interim report in accordance with the IAS 34 standard. The figures are unaudited.The transmission reliability rate of Fingrid’s transmission system was very high. Electricity consumption in Finland grew moderately in January–September,...

Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study Target Current Pediatric Patient in Ongoing Study Has Completely Healed Skin After 9 months of ‘Whole Body’ Treatment Investigator’s Global Assessment (IGA) Materially Improved from Baseline 4 (Severe) to 0 (Clear) Pruritus (itch) Reduced from 5 at baseline to 0, reflecting a complete absence of pruritus High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications and is Experiencing Zero Nightly Sleep Disturbance No Adverse Events Reported After 9 Months of Continuous Dosing with QRX003ASHBURN, Va., Oct. 28, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical...

MANITOWOC, Wis., Oct. 28, 2025 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced LED lighting and Electrical Infrastructure engagements representing revenue of more than $4.7 million for two major enterprise customers. The larger of the two engagements, valued at $3.6 million in revenue, calls for installations and upgrades of Electrical Infrastructure and LED lighting at facilities of a large enterprise with a workforce of 18,000 employees. The second engagement, expected to be completed during Orion’s current fiscal year of FY 2026, includes installations and upgrades of Electrical Infrastructure and LED lighting at five facilities in four U.S. states. The $1 million...